Silence Therapeutics plc Number Of Share Options Exercisable In Share-based Payment Arrangement
Silence Therapeutics plc (SLNCF) had Number Of Share Options Exercisable In Share-based Payment Arrangement of 2.42 million AmericanDepositarySh as of 2023-12-31, per its 20-F filed 2024-03-13.
Discontinued › Notes › Compensation Related Costs
ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement · last filed 2024-03-13
- 2021-12-31: Number Of Share Options Exercisable In Share-based Payment Arrangement 2.50M shares.
- 2020-12-31: Number Of Share Options Exercisable In Share-based Payment Arrangement 1.08M shares.
- 2019-12-31: Number Of Share Options Exercisable In Share-based Payment Arrangement 647.22K shares.
- 2018-12-31: Number Of Share Options Exercisable In Share-based Payment Arrangement 2.69M shares.
shares
| Period end | Number Of Share Options Exercisable In Share-based Payment Arrangement |
|---|---|
| 2021-12-31 | 2.50M shares 20-F · filed 2024-03-13 |
| 2020-12-31 | 1.08M shares 20-F · filed 2023-03-15 |
| 2019-12-31 | 647.22K shares 20-F · filed 2022-03-17 |
| 2018-12-31 | 2.69M shares 20-F/A · filed 2021-04-29 |
AmericanDepositarySh
| Period end | Number Of Share Options Exercisable In Share-based Payment Arrangement |
|---|---|
| 2023-12-31 | 2.42M AmericanDepositarySh 20-F · filed 2024-03-13 |
| 2022-12-31 | 1.89M AmericanDepositarySh 20-F · filed 2024-03-13 |